OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
CBSC
Cardiac Biotech Solutions Inc.
0.044
0.00
0.00%
0.0402 / 0.0499 (10000 x 10000)
Cardiac Biotech Solutions Inc.
10845 Griffith Peak Drive
Suite 200
Las Vegas, NV 89135
Trip Thomas is the CFO and President of A-Frame Accounting & Advisory, Inc. located in Tampa, Florida. Trip has more than 19 years of experience in the field of accounting and holds a Bachelor of Science in Accounting from the University of Tampa and a Bachelor of Science in Agribusiness from the University of Florida. He is a licensed CPA in the State of Florida. His experience includes private industry, public company, public accounting and non-profit. Some of his experience includes auditing, budget analysis, fixed assets, financial modeling, SEC financial reporting, GAAP compliance, and fair value measurements. Before founding A-Frame, Trip spent five years as a partner with Cross Roads Consulting, LLC, a boutique consulting practice, located in Tampa, Florida. At Cross Roads he assisted clients in the areas of (i) Regulatory financial reporting, (ii) GAAP and IFRS compliance and (iii) technical accounting support. Prior to working for Cross Roads, Trip worked as a Senior Accountant for The LSC Group LLC, a licensed CPA firm, located in Tampa, Florida. At The LSC Group, he specialized in the identification and valuation of derivatives arising from PIPE (Private Investment in a Public Entity) transactions. Prior to working for The LSC Group, Trip worked as an accountant for a diverse range of organizations, including a Tampa real estate developer, the American Heart Association (a non-profit organization) and MetLife (a fortune five hundred corporation).
None
3419 W Gray Ct.
Tampa, FL 33609
1101 Pennsylvania Avenue, N.W,
Suite 200
Washington, DC 20006
1701 Pennsylvania Ave, NW
Suite 200
Washington, DC 20006
OR, US, 1987
On June 22, 2020, the Company completed an acquisition of the assets of Prevent Health Care International Corporation (“PHCIC”), a private British Columbia, Canada corporation involved in the development, sale and service of an innovative arrhythmia diagnostic and heart-monitoring intellectual property, and related products. The primary assets of PHCIC are its wholly-owned subsidiaries: MyCardia (USA) Inc., incorporated in California, MyCardia (HK) Ltd., incorporated in Hong Kong, China, and Shenzhen Maikadi Medical Technology, Ltd. incorporated in China. MyCardia (USA) Inc. is a fully operating company whereas MyCardia (HK) Ltd. and Shenzhen Maikadi Medical Technology, Ltd. do not yet have operations. The acquired products and services are available in the U.S. and through PHCIC’s international subsidiaries using proprietary FDA and CE-cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms. The combination of devices and software provides improved compliance for patients at risk of abnormal heart rhythms, as well as more accurate information for physicians.
Current facilities for the company include our main corporate location at a WeWork office facility located at 10845 Griffith Peak Drive, Suite 200, Las Vegas, NV 89135 on a monthly rental. We also utilize manufacturing space in connection with our business relationship with Datrix, LLC at 340 State Place in Escondido, California 92029. We remain in the negotiating process towards acquiring Datrix, LLC. We believe that this facility adequately meets our current manufacturing needs, including providing the space and infrastructure to accommodate our future development work based on our current operating plan. We do not currently own any real estate.
